Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Burger

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Cancer|August 1, 1986
Malignant Brenner tumor. A histologic, morphometrical, immunohistochemical, and ultrastructural studyC A Seldenrijk, A P Willig, J P Baak, et al.
Cancer Letters|January 15, 1993
The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-alpha treatmentC D Richters, C W Burger, A A van de Loosdrecht, et al.
Oncology|January 17, 2008
Preoperative predictors for residual tumor after surgery in patients with ovarian carcinomaD de Jong, M J Eijkemans, S Lie Fong, et al.
Acta Physiologica (Oxford, England)|July 27, 2016
Progesterone-induced miR-133a inhibits the proliferation of endometrial epithelial cellsJ-L Pan, D-Z Yuan, Y-B Zhao, et al.
Human Reproduction (Oxford, England)|April 9, 2005
Effects of subfertility cause, smoking and body weight on the success rate of IVFA M E Lintsen, P C M Pasker-de Jong, E J de Boer, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 4, 2009
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinomaC G Gerestein, M J C Eijkemans, D de Jong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patientsP M L H Vencken, M Kriege, D Hoogwerf, et al.
Journal of Molecular Endocrinology|December 16, 2006
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell lineP Hanifi-Moghaddam, B Sijmons, M C Ott, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 10, 2014
Progesterone-induced cyclin G1 inhibits the proliferation of endometrial epithelial cell and its possible molecular mechanismD-z Yuan, X-l Ding, H-l Yu, et al.
Reproductive Biomedicine Online|September 30, 2006
Optimum number of oocytes for a successful first IVF treatment cycleM H van der Gaast, M J C Eijkemans, J B van der Net, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Cancer|August 1, 1986
Malignant Brenner tumor. A histologic, morphometrical, immunohistochemical, and ultrastructural studyC A Seldenrijk, A P Willig, J P Baak, et al.
Cancer Letters|January 15, 1993
The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-alpha treatmentC D Richters, C W Burger, A A van de Loosdrecht, et al.
Oncology|January 17, 2008
Preoperative predictors for residual tumor after surgery in patients with ovarian carcinomaD de Jong, M J Eijkemans, S Lie Fong, et al.
Acta Physiologica (Oxford, England)|July 27, 2016
Progesterone-induced miR-133a inhibits the proliferation of endometrial epithelial cellsJ-L Pan, D-Z Yuan, Y-B Zhao, et al.
Human Reproduction (Oxford, England)|April 9, 2005
Effects of subfertility cause, smoking and body weight on the success rate of IVFA M E Lintsen, P C M Pasker-de Jong, E J de Boer, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 4, 2009
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinomaC G Gerestein, M J C Eijkemans, D de Jong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patientsP M L H Vencken, M Kriege, D Hoogwerf, et al.
Journal of Molecular Endocrinology|December 16, 2006
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell lineP Hanifi-Moghaddam, B Sijmons, M C Ott, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 10, 2014
Progesterone-induced cyclin G1 inhibits the proliferation of endometrial epithelial cell and its possible molecular mechanismD-z Yuan, X-l Ding, H-l Yu, et al.
Reproductive Biomedicine Online|September 30, 2006
Optimum number of oocytes for a successful first IVF treatment cycleM H van der Gaast, M J C Eijkemans, J B van der Net, et al.
Pageof 9